Document is current
Any future updates will be listed below
-
Authors
Nagata, Jason M. https://orcid.org/0000-0002-6541-0604
Compte, Emilio J.
Cattle, Chloe J.
Flentje, Annesa
Capriotti, Matthew R.
Lubensky, Micah E.
Murray, Stuart B.
Obedin-Maliver, Juno
Lunn, Mitchell R.
-
Funding
Funding for this research was provided by:
Pediatric Scientist Development Program
American Academy of Neurology
National Institutes of Health (K23 MH115184)
National Institute of Diabetes and Digestive and Kidney Diseases (K12DK111028)
National Institute on Drug Abuse (K23DA039800)
- License Information
-
More Information
Article History
Received: 11 September 2020
Accepted: 10 November 2020
First Online: 8 December 2020
Ethics approval and consent to participate
: The University of California, San Francisco Institutional Review Board approved this study (#16–21213). Written informed consent was obtained from all participants.
: Not applicable.
: Dr. Juno Obedin-Maliver has consulted for Sage Therapeutics (5/2017) in a one-day advisory board, Ibis Reproductive Health (a non-for-profit research group 3/2017–5/2018), Hims Inc. (2019 - present), and Folx, Inc. (2020 – present). Dr. Lunn has consulted for Hims Inc. (2019 - present) and Folx, Inc. (2020 - present). None of these roles present a conflict of interest with this work as described here. The other authors have no conflicts of interest to report.
